Loading clinical trials...
Loading clinical trials...
Avonex Pregnancy Exposure Registry
Conditions
Interventions
BG9418 (interferon beta-1a)
Locations
1
United States
Kendle
Wilmington, North Carolina, United States
Start Date
February 1, 2004
Primary Completion Date
September 1, 2011
Completion Date
September 1, 2011
Last Updated
June 9, 2014
NCT06276634
NCT07225504
NCT06768060
NCT06809192
NCT05359653
NCT07462065
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions